Racial differences in the association of insulin-like growth factor pathway and colorectal adenoma risk

Heather M. Ochs-Balcom, Caila B. Vaughn, Jing Nie, Zhengyi Chen, Cheryl L. Thompson, Niyati Parekh, Russell Tracy, Li Li

Research output: Contribution to journalArticle

Abstract

Purpose: Insulin resistance is believed to play an important role in the link between energy imbalance and colon carcinogenesis. Emerging evidence suggests that there are substantial racial differences in genetic and anthropometric influences on insulin-like growth factors (IGFs); however, few studies have examined racial differences in the associations of IGFs and colorectal adenoma, precursor lesions of colon cancer. Methods: We examined the association of circulating levels of IGF-1, IGFBP-3 and IGFBP-1, and SNPs in the IGF-1 receptor (IGF1R), IGF-2 receptor (IGF2R), and insulin receptor genes with risk of adenomas in a sample of 410 incident adenoma cases and 1,070 controls from the Case Transdisciplinary Research on Energetics and Cancer (TREC) Colon Adenomas Study. Results: Caucasians have higher IGF-1 levels compared to African Americans; mean IGF-1 levels are 119.0 ng/ml (SD = 40.7) and 109.8 ng/ml (SD = 40.8), respectively, among cases (p = 0.02). Mean IGF-1 levels are also higher in Caucasian controls (122.9 ng/ml, SD = 41.2) versus African American controls (106.9, SD = 41.2), p = 0.001. We observed similar differences in IGFBP3 levels by race. Logistic regression models revealed a statistically significant association of IGF-1 with colorectal adenoma in African Americans only, with adjusted odds ratios (ORs) of 1.68 (95 % CI 1.06-2.68) and 1.68 (95 % CI 1.05-2.71), respectively, for the second and third tertiles as compared to the first tertile. One SNP (rs496601) in IGF1R was associated with adenomas in Caucasians only; the per allele adjusted OR is 0.73 (95 % CI 0.57-0.93). Similarly, one IGF2R SNP (rs3777404) was statistically significant in Caucasians; adjusted per allele OR is 1.53 (95 % CI 1.10-2.14). Conclusion: Our results suggest racial differences in the associations of IGF pathway biomarkers and inherited genetic variance in the IGF pathway with risk of adenomas that warrant further study.

Original languageEnglish (US)
Pages (from-to)161-170
Number of pages10
JournalCancer Causes and Control
Volume25
Issue number2
DOIs
StatePublished - Feb 2014

Fingerprint

Somatomedins
Adenoma
African Americans
Single Nucleotide Polymorphism
Somatomedin Receptors
Odds Ratio
Colonic Neoplasms
Logistic Models
Alleles
IGF Type 2 Receptor
Insulin-Like Growth Factor Binding Protein 1
IGF Type 1 Receptor
Insulin-Like Growth Factor Binding Protein 3
Insulin Receptor
Insulin Resistance
Colon
Carcinogenesis
Biomarkers
Research

Keywords

  • African American
  • Candidate gene
  • Colorectal adenoma
  • Insulin-like growth factor
  • Obesity

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Racial differences in the association of insulin-like growth factor pathway and colorectal adenoma risk. / Ochs-Balcom, Heather M.; Vaughn, Caila B.; Nie, Jing; Chen, Zhengyi; Thompson, Cheryl L.; Parekh, Niyati; Tracy, Russell; Li, Li.

In: Cancer Causes and Control, Vol. 25, No. 2, 02.2014, p. 161-170.

Research output: Contribution to journalArticle

Ochs-Balcom, Heather M. ; Vaughn, Caila B. ; Nie, Jing ; Chen, Zhengyi ; Thompson, Cheryl L. ; Parekh, Niyati ; Tracy, Russell ; Li, Li. / Racial differences in the association of insulin-like growth factor pathway and colorectal adenoma risk. In: Cancer Causes and Control. 2014 ; Vol. 25, No. 2. pp. 161-170.
@article{4a52a1fcaab34eea853b4e64168efa7e,
title = "Racial differences in the association of insulin-like growth factor pathway and colorectal adenoma risk",
abstract = "Purpose: Insulin resistance is believed to play an important role in the link between energy imbalance and colon carcinogenesis. Emerging evidence suggests that there are substantial racial differences in genetic and anthropometric influences on insulin-like growth factors (IGFs); however, few studies have examined racial differences in the associations of IGFs and colorectal adenoma, precursor lesions of colon cancer. Methods: We examined the association of circulating levels of IGF-1, IGFBP-3 and IGFBP-1, and SNPs in the IGF-1 receptor (IGF1R), IGF-2 receptor (IGF2R), and insulin receptor genes with risk of adenomas in a sample of 410 incident adenoma cases and 1,070 controls from the Case Transdisciplinary Research on Energetics and Cancer (TREC) Colon Adenomas Study. Results: Caucasians have higher IGF-1 levels compared to African Americans; mean IGF-1 levels are 119.0 ng/ml (SD = 40.7) and 109.8 ng/ml (SD = 40.8), respectively, among cases (p = 0.02). Mean IGF-1 levels are also higher in Caucasian controls (122.9 ng/ml, SD = 41.2) versus African American controls (106.9, SD = 41.2), p = 0.001. We observed similar differences in IGFBP3 levels by race. Logistic regression models revealed a statistically significant association of IGF-1 with colorectal adenoma in African Americans only, with adjusted odds ratios (ORs) of 1.68 (95 {\%} CI 1.06-2.68) and 1.68 (95 {\%} CI 1.05-2.71), respectively, for the second and third tertiles as compared to the first tertile. One SNP (rs496601) in IGF1R was associated with adenomas in Caucasians only; the per allele adjusted OR is 0.73 (95 {\%} CI 0.57-0.93). Similarly, one IGF2R SNP (rs3777404) was statistically significant in Caucasians; adjusted per allele OR is 1.53 (95 {\%} CI 1.10-2.14). Conclusion: Our results suggest racial differences in the associations of IGF pathway biomarkers and inherited genetic variance in the IGF pathway with risk of adenomas that warrant further study.",
keywords = "African American, Candidate gene, Colorectal adenoma, Insulin-like growth factor, Obesity",
author = "Ochs-Balcom, {Heather M.} and Vaughn, {Caila B.} and Jing Nie and Zhengyi Chen and Thompson, {Cheryl L.} and Niyati Parekh and Russell Tracy and Li Li",
year = "2014",
month = "2",
doi = "10.1007/s10552-013-0318-6",
language = "English (US)",
volume = "25",
pages = "161--170",
journal = "Cancer Causes and Control",
issn = "0957-5243",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Racial differences in the association of insulin-like growth factor pathway and colorectal adenoma risk

AU - Ochs-Balcom, Heather M.

AU - Vaughn, Caila B.

AU - Nie, Jing

AU - Chen, Zhengyi

AU - Thompson, Cheryl L.

AU - Parekh, Niyati

AU - Tracy, Russell

AU - Li, Li

PY - 2014/2

Y1 - 2014/2

N2 - Purpose: Insulin resistance is believed to play an important role in the link between energy imbalance and colon carcinogenesis. Emerging evidence suggests that there are substantial racial differences in genetic and anthropometric influences on insulin-like growth factors (IGFs); however, few studies have examined racial differences in the associations of IGFs and colorectal adenoma, precursor lesions of colon cancer. Methods: We examined the association of circulating levels of IGF-1, IGFBP-3 and IGFBP-1, and SNPs in the IGF-1 receptor (IGF1R), IGF-2 receptor (IGF2R), and insulin receptor genes with risk of adenomas in a sample of 410 incident adenoma cases and 1,070 controls from the Case Transdisciplinary Research on Energetics and Cancer (TREC) Colon Adenomas Study. Results: Caucasians have higher IGF-1 levels compared to African Americans; mean IGF-1 levels are 119.0 ng/ml (SD = 40.7) and 109.8 ng/ml (SD = 40.8), respectively, among cases (p = 0.02). Mean IGF-1 levels are also higher in Caucasian controls (122.9 ng/ml, SD = 41.2) versus African American controls (106.9, SD = 41.2), p = 0.001. We observed similar differences in IGFBP3 levels by race. Logistic regression models revealed a statistically significant association of IGF-1 with colorectal adenoma in African Americans only, with adjusted odds ratios (ORs) of 1.68 (95 % CI 1.06-2.68) and 1.68 (95 % CI 1.05-2.71), respectively, for the second and third tertiles as compared to the first tertile. One SNP (rs496601) in IGF1R was associated with adenomas in Caucasians only; the per allele adjusted OR is 0.73 (95 % CI 0.57-0.93). Similarly, one IGF2R SNP (rs3777404) was statistically significant in Caucasians; adjusted per allele OR is 1.53 (95 % CI 1.10-2.14). Conclusion: Our results suggest racial differences in the associations of IGF pathway biomarkers and inherited genetic variance in the IGF pathway with risk of adenomas that warrant further study.

AB - Purpose: Insulin resistance is believed to play an important role in the link between energy imbalance and colon carcinogenesis. Emerging evidence suggests that there are substantial racial differences in genetic and anthropometric influences on insulin-like growth factors (IGFs); however, few studies have examined racial differences in the associations of IGFs and colorectal adenoma, precursor lesions of colon cancer. Methods: We examined the association of circulating levels of IGF-1, IGFBP-3 and IGFBP-1, and SNPs in the IGF-1 receptor (IGF1R), IGF-2 receptor (IGF2R), and insulin receptor genes with risk of adenomas in a sample of 410 incident adenoma cases and 1,070 controls from the Case Transdisciplinary Research on Energetics and Cancer (TREC) Colon Adenomas Study. Results: Caucasians have higher IGF-1 levels compared to African Americans; mean IGF-1 levels are 119.0 ng/ml (SD = 40.7) and 109.8 ng/ml (SD = 40.8), respectively, among cases (p = 0.02). Mean IGF-1 levels are also higher in Caucasian controls (122.9 ng/ml, SD = 41.2) versus African American controls (106.9, SD = 41.2), p = 0.001. We observed similar differences in IGFBP3 levels by race. Logistic regression models revealed a statistically significant association of IGF-1 with colorectal adenoma in African Americans only, with adjusted odds ratios (ORs) of 1.68 (95 % CI 1.06-2.68) and 1.68 (95 % CI 1.05-2.71), respectively, for the second and third tertiles as compared to the first tertile. One SNP (rs496601) in IGF1R was associated with adenomas in Caucasians only; the per allele adjusted OR is 0.73 (95 % CI 0.57-0.93). Similarly, one IGF2R SNP (rs3777404) was statistically significant in Caucasians; adjusted per allele OR is 1.53 (95 % CI 1.10-2.14). Conclusion: Our results suggest racial differences in the associations of IGF pathway biomarkers and inherited genetic variance in the IGF pathway with risk of adenomas that warrant further study.

KW - African American

KW - Candidate gene

KW - Colorectal adenoma

KW - Insulin-like growth factor

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=84893698177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893698177&partnerID=8YFLogxK

U2 - 10.1007/s10552-013-0318-6

DO - 10.1007/s10552-013-0318-6

M3 - Article

C2 - 24194259

AN - SCOPUS:84893698177

VL - 25

SP - 161

EP - 170

JO - Cancer Causes and Control

JF - Cancer Causes and Control

SN - 0957-5243

IS - 2

ER -